Livzon Pharmaceutical Group Inc (000513) — Net Asset Momentum
Livzon Pharmaceutical Group Inc (000513) recorded a net asset momentum of 5.9% as of December 2025, with net assets of CN¥15.79 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Livzon Pharmaceutical Group Inc (000513) shareholders funds for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Livzon Pharmaceutical Group Inc Net Asset Momentum (1992–2025)
This chart tracks Livzon Pharmaceutical Group Inc's year-over-year net asset growth across 34 annual reporting periods from 1992 to 2025. The most recent momentum reading is +5.9%, with net assets of CN¥15.79 Billion CNY as of December 2025. For live market cap and overall valuation, see 000513 market cap overview.
Annual Net Asset History for Livzon Pharmaceutical Group Inc (1992–2025)
The table below shows the complete annual net asset history for Livzon Pharmaceutical Group Inc from 1992 to 2025, covering 34 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 000513 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥15.79 Billion | CN¥23.99 Billion | CN¥8.20 Billion | ▲ +5.9% |
| 2024 | CN¥14.91 Billion | CN¥24.46 Billion | CN¥9.55 Billion | ▲ +0.9% |
| 2023 | CN¥14.77 Billion | CN¥25.04 Billion | CN¥10.28 Billion | ▼ -1.1% |
| 2022 | CN¥14.94 Billion | CN¥24.87 Billion | CN¥9.93 Billion | ▲ +4.4% |
| 2021 | CN¥14.31 Billion | CN¥22.37 Billion | CN¥8.06 Billion | ▲ +4.9% |
| 2020 | CN¥13.64 Billion | CN¥20.59 Billion | CN¥6.95 Billion | ▲ +11.1% |
| 2019 | CN¥12.28 Billion | CN¥17.98 Billion | CN¥5.70 Billion | ▲ +4.5% |
| 2018 | CN¥11.75 Billion | CN¥17.44 Billion | CN¥5.69 Billion | ▲ +4.6% |
| 2017 | CN¥11.23 Billion | CN¥15.90 Billion | CN¥4.66 Billion | ▲ +58.1% |
| 2016 | CN¥7.11 Billion | CN¥10.53 Billion | CN¥3.42 Billion | ▲ +47.7% |
| 2015 | CN¥4.81 Billion | CN¥8.08 Billion | CN¥3.27 Billion | ▲ +17.8% |
| 2014 | CN¥4.08 Billion | CN¥7.30 Billion | CN¥3.22 Billion | ▲ +13.3% |
| 2013 | CN¥3.60 Billion | CN¥6.57 Billion | CN¥2.96 Billion | ▲ +13.3% |
| 2012 | CN¥3.18 Billion | CN¥5.63 Billion | CN¥2.45 Billion | ▲ +5.6% |
| 2011 | CN¥3.01 Billion | CN¥4.60 Billion | CN¥1.59 Billion | ▲ +14.1% |
| 2010 | CN¥2.64 Billion | CN¥3.66 Billion | CN¥1.02 Billion | ▲ +18.6% |
| 2009 | CN¥2.23 Billion | CN¥3.12 Billion | CN¥898.92 Million | ▲ +21.3% |
| 2008 | CN¥1.83 Billion | CN¥2.92 Billion | CN¥1.09 Billion | ▼ -7.9% |
| 2007 | CN¥1.99 Billion | CN¥2.95 Billion | CN¥954.80 Million | ▲ +38.4% |
| 2006 | CN¥1.44 Billion | CN¥2.52 Billion | CN¥1.08 Billion | ▲ +16.2% |
| 2005 | CN¥1.24 Billion | CN¥2.16 Billion | CN¥925.20 Million | ▲ +5.7% |
| 2004 | CN¥1.17 Billion | CN¥2.20 Billion | CN¥1.03 Billion | ▼ -0.2% |
| 2003 | CN¥1.17 Billion | CN¥2.13 Billion | CN¥954.70 Million | ▲ +3.9% |
| 2002 | CN¥1.13 Billion | CN¥1.86 Billion | CN¥727.05 Million | ▲ +9.5% |
| 2001 | CN¥1.03 Billion | CN¥1.67 Billion | CN¥639.37 Million | ▲ +6.8% |
| 2000 | CN¥967.05 Million | CN¥1.55 Billion | CN¥581.24 Million | ▼ -0.7% |
| 1999 | CN¥973.90 Million | CN¥1.56 Billion | CN¥583.95 Million | ▲ +0.2% |
| 1998 | CN¥972.07 Million | CN¥1.44 Billion | CN¥467.61 Million | ▼ -6.1% |
| 1997 | CN¥1.04 Billion | CN¥1.51 Billion | CN¥474.51 Million | ▲ +34.6% |
| 1996 | CN¥769.62 Million | CN¥1.32 Billion | CN¥547.10 Million | ▲ +16.2% |
| 1995 | CN¥662.32 Million | CN¥1.11 Billion | CN¥447.49 Million | ▲ +6.2% |
| 1994 | CN¥623.47 Million | CN¥870.12 Million | CN¥246.65 Million | ▲ +14.0% |
| 1993 | CN¥546.67 Million | CN¥797.27 Million | CN¥250.60 Million | ▲ +98.4% |
| 1992 | CN¥275.56 Million | CN¥594.26 Million | CN¥318.71 Million | — |